Description
549-P03531 - 549-10-2-069-0311 - BOSENTAN - PROCARE PHARMACY INC - PHARMACY SERVICE - FY 10
Modification chain · 1 transaction
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2010-02-10+$5,567= $5,567
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2010-02-10 | +$5,567 | $5,567 | 549-P03531 - 549-10-2-069-0311 - BOSENTAN - PROCARE PHARMACY INC - PHARMACY SERVICE - FY 10 |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI MMKYFJ5QGKM7)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C24625P0609 | 246-NETWORK CONTRACTING OFFICE 6 (36C246) · 6505 · DRUGS AND BIOLOGICALS | $19,887 | FY2025 |
| 36C24625P0544 | 246-NETWORK CONTRACTING OFFICE 6 (36C246) · 6505 · DRUGS AND BIOLOGICALS | $19,887 | FY2025 |
| 36C26224P2170 | 262-NETWORK CONTRACT OFFICE 22 (36C262) · 6505 · DRUGS AND BIOLOGICALS | $11,281 | FY2024 |
| 36C25524P0492 | 255-NETWORK CONTRACT OFFICE 15 (36C255) · 6515 · MEDICAL AND SURGICAL INSTRUMENTS, EQUIPMENT, AND SUPPLIES | $329,479 | FY2024 |
| 36C24818P6480 | 248-NETWORK CONTRACT OFFICE 8 (36C248) · 6505 · DRUGS AND BIOLOGICALS | $11,754 | FY2018 |
| 36C24818P0529 | 248-NETWORK CONTRACT OFFICE 8 (36C248) · 6505 · DRUGS AND BIOLOGICALS | $11,754 | FY2018 |
Other recipients under 6505 from 549-DALLAS (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| VA25716P0113 | MCKESSON CORPORATION | 549-DALLAS | $11,630 | FY2016 |
| VA25716P0178 | MICROGENICS CORPORATION | 549-DALLAS | $109,260 | FY2016 |
| VA25715J2597 | GRIFOLS BIOLOGICALS LLC | 549-DALLAS | $129,005 | FY2015 |
| VA25715C0028 | BARD PERIPHERAL VASCULAR, INC. | 549-DALLAS | $11,400 | FY2015 |
| VA25714J3693 | TALECRIS BIOTHERAPEUTICS HOLDINGS CORP. | 549-DALLAS | $7,512 | FY2014 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_VA549P03531_3600_-NONE-_-NONE- · retrieved 2026-09-26.